2023-04-26 06:07:38 ET
- Integra LifeSciences Holdings press release ( NASDAQ: IART ): Q1 Non-GAAP EPS of $0.74 in-line.
- Revenue of $380.8M (+1.1% Y/Y) beats by $7.59M .
- Adjusted gross margin was 67.3%, compared to 67.7% in the prior year.
- Adjusted EBITDA for the first quarter of 2023 was $92.3 million, or 24.2% of revenue, compared to $93.5 million million, or 24.8% of revenue, in the prior year.
- The Company is reaffirming its full-year 2023 revenue and adjusted earnings per share guidance with a range of $1,602 million to $1,620 million vs. consensus of $1.61B and $3.43 to $3.51 vs. consensus of $3.48 respectively.
For further details see:
Integra LifeSciences Holdings beats Q1 top line estimates; reaffirms FY23 outlook